COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,627 Articles (22,913 medRxiv, 8,714 bioRxiv)

Most recent first Previous |  Page 908: Articles 9071-9080  | Next

Selective visuoconstructional impairment following mild COVID-19 with inflammatory and neuroimaging correlation findings.
DE PAULA, J. J., Paiva, R. E. R. P. d., Silva, N. G. S. e., Rosa, D. V. F., Duran, F. L. d. S., Coimbra, R. S., Costa, D. d. S., Dutenhefner, P. R., Oliveira, H. S. D., Camargos, S. T., Vasconcelos, H. M., Carvalho, N. d. O., Silva, J. B., Silveira, M. B., Malamut, C., Oliveira, D. M., Molinari, L. C., Oliveira, D. B. d., Januario, J. N., Silva, L. C., De Marco, L. A., Queiroz, D. M. M., Meira, W., Busatto, G., Miranda, D. M. d., Romano-Silva, M. A.
10.1101/2022.03.16.22272467 — Posted: 2022-03-18
Serological Responses to the First Three Doses of SARS-CoV-2 Vaccination in Inflammatory Bowel Disease: A Prospective Cohort Study
Quan, J., Ma, C., Panaccione, R., Hracs, L., Sharifi, N., Herauf, M., Markovinovic, A., Coward, S., Windsor, J. W., Caplan, L., Ingram, R. J. M., Kanji, J. N., Tipples, G., Holodinsky, J. K., Bernstein, C. N., Mahoney, D. J., Bernatsky, S., Benchimol, E. I., Kaplan, G. G., Serological Testing to Outline Protocols for COVID19 in Inflammatory Bowel Disease Research Group
10.1101/2022.03.16.22272440 — Posted: 2022-03-18
Variant-specific burden of SARS-CoV-2 in Michigan: March 2020 through November 2021
Petrie, J. G., Eisenberg, M. C., Lauring, A. S., Gilbert, J., Harrison, S. M., DeJonge, P. M., Martin, E. T.
10.1101/2022.03.16.22272497 — Posted: 2022-03-18
The decay of coronavirus in sewage pipes and the development of a predictive model for the estimation of SARS-CoV-2 infection cases based on wastewater surveillance
Fu, S., Wang, Q., He, F., Zhou, C., Zhang, J., Xia, W.
10.1101/2022.03.16.22272521 — Posted: 2022-03-18
Humoral and cellular immune responses to CoronaVac assessed up to one year after vaccination
Costa, P. R., Correia, C. A., Marmorato, M. P., Dias, J. Z. d. C., Thomazella, M. V., Silva, A. C. d., Oliveira, A. C. S. d., Gusmao, A. F., Ferrari, L., Freitas, A., Patino, E. G., Grifoni, A., Weiskopf, D., Sette, A., Tran, T. C., Nguyen, H. M., Mercer, L. D., Raghunandan, R., Lal, M., White, J. A., Hjorth, R., Innis, B. L., Scharf, R., Kallas, E. G., Silveira, C. G. T., PROFISCOV study group
10.1101/2022.03.16.22272513 — Posted: 2022-03-18
Outdoor long-range transmission of COVID-19 and patient zero
Rowe, B. R., Mitchell, J. B. A., Canosa, A.
10.1101/2022.03.16.22272493 — Posted: 2022-03-18
Detection of bacterial co-infections and prediction of fatal outcomes in COVID-19 patients presenting to the emergency department using a 29 mRNA host response classifier.
Ram-Mohan, N., Rogers, A. J., Blish, C. A., Nadeau, K. C., Zudock, E. J., Kim, D., Quinn, J. V., Sun, L., Liesenfeld, O., the Stanford COVID-19 Biobank Study Group, , Yang, S.
10.1101/2022.03.14.22272394 — Posted: 2022-03-17
Broad neutralization of SARS-CoV-2 variants by circular mRNA producing VFLIP-X spike in mice
Seephetdee, C., Bhukhai, K., Buasri, N., Leelukkanaveera, P., Lerdwattanasombat, P., Manopwisedjaroen, S., Phueakphud, N., Kuhaudomlarp, S., Ollmann Saphire, E., Thitithanyanont, A., Hongeng, S., Wongtrakoongate, P.
10.1101/2022.03.17.484759 — Posted: 2022-03-17
The effect of waning on antibody levels and memory B cell recall following SARS-CoV-2 infection or vaccination
Forgacs, D., Moraes, V. S., Hanley, H. B., Gattiker, J. L., Jefferson, A. M., Ross, T. M.
10.1101/2022.03.16.484099 — Posted: 2022-03-17
Long-term T cell perturbations and waning antibody levels in individuals needing hospitalization for COVID-19
Govender, M., Hopkins, F. R., Goransson, R., Svanberg, C., Muthu, S. E., Hjorth, M., Augustinsson, A. N., Sjowall, J., Nystrom, S., Larsson, M.
10.1101/2022.03.17.484640 — Posted: 2022-03-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).